The Effect of Genotyping on the Number of Pharmacotherapeutic Gene-Drug Interventions in Chronic Kidney Disease Patients

• Main Authors: Catharina H. M. Kerskes (Author), Carien J. M. E. van den Eijnde (Author), Albert-Jan L. H. J. Aarnoudse (Author), René J. E. Grouls (Author), Birgit A. L. M. Deiman (Author), Maarten J. Deenen (Author)
• Format: Book
• Published: MDPI AG, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Patients with chronic kidney disease (CKD) stage 3-5 are polypharmacy patients. Many of these drugs are metabolized by cytochrome P450 (<i>CYP450</i>) and <i>CYP450.</i> Genetic polymorphism is well known to result in altered drug metabolism capacity. This study determined th...